| Primary |
| Parkinson's Disease |
26.2% |
| Prolactinoma |
19.8% |
| Pituitary Tumour Benign |
11.9% |
| Hyperprolactinaemia |
7.9% |
| Autonomic Nervous System Imbalance |
4.8% |
| Aphasia |
4.0% |
| Lactation Inhibition Therapy |
3.2% |
| Neuroleptic Malignant Syndrome |
3.2% |
| Respiratory Tract Infection |
3.2% |
| Vulvovaginal Mycotic Infection |
3.2% |
| Parkinsonism |
2.4% |
| Prolactin-producing Pituitary Tumour |
2.4% |
| Breast Engorgement |
1.6% |
| Mastitis |
1.6% |
| Acromegaly |
0.8% |
| Adenoma Benign |
0.8% |
| Blood Prolactin Increased |
0.8% |
| Congenital Heart Valve Disorder |
0.8% |
| Drug Therapy |
0.8% |
| Headache |
0.8% |
|
| Drug Exposure During Pregnancy |
7.9% |
| Trigeminal Neuralgia |
7.9% |
| Foetal Exposure During Pregnancy |
6.3% |
| Impulse-control Disorder |
6.3% |
| Premature Baby |
6.3% |
| Premature Labour |
6.3% |
| Suicide Attempt |
6.3% |
| Vomiting |
6.3% |
| Hallucination, Visual |
4.8% |
| Headache |
4.8% |
| Nausea |
4.8% |
| Pathological Gambling |
4.8% |
| Peripheral Ischaemia |
4.8% |
| Autonomic Nervous System Imbalance |
3.2% |
| Death |
3.2% |
| Hypersexuality |
3.2% |
| Intentional Drug Misuse |
3.2% |
| Lymphocytic Hypophysitis |
3.2% |
| Mitral Valve Disease |
3.2% |
| Mucosal Dryness |
3.2% |
|
| Secondary |
| Parkinson's Disease |
27.2% |
| Drug Use For Unknown Indication |
12.2% |
| Prolactinoma |
10.2% |
| Hyperprolactinaemia |
6.1% |
| Product Used For Unknown Indication |
6.1% |
| Glaucoma |
4.1% |
| Hypertension |
4.1% |
| Lactation Inhibition Therapy |
4.1% |
| Psychotic Disorder |
4.1% |
| Pituitary Tumour Benign |
3.4% |
| Hyperlipidaemia |
2.7% |
| Muscle Tightness |
2.7% |
| Acromegaly |
2.0% |
| Convulsion |
2.0% |
| Pituitary Tumour |
2.0% |
| Aphasia |
1.4% |
| Cardiovascular Event Prophylaxis |
1.4% |
| Congenital Heart Valve Disorder |
1.4% |
| Constipation |
1.4% |
| Diabetes Mellitus |
1.4% |
|
| Nausea |
17.0% |
| Vomiting |
12.8% |
| Death |
6.4% |
| Somnolence |
6.4% |
| Ventricular Tachycardia |
6.4% |
| Delusion |
4.3% |
| Extrapyramidal Disorder |
4.3% |
| Neuroleptic Malignant Syndrome |
4.3% |
| On And Off Phenomenon |
4.3% |
| Polyneuropathy |
4.3% |
| Trigeminal Neuralgia |
4.3% |
| Urinary Tract Infection |
4.3% |
| Visual Field Defect |
4.3% |
| Weight Decreased |
4.3% |
| Adverse Reaction |
2.1% |
| Alanine Aminotransferase Increased |
2.1% |
| Breast Pain |
2.1% |
| Drug Abuse |
2.1% |
| Drug Ineffective |
2.1% |
| Gambling |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
14.1% |
| Parkinson's Disease |
13.5% |
| Drug Use For Unknown Indication |
8.6% |
| Hypertension |
6.7% |
| Depression |
6.4% |
| Muscle Spasms |
4.3% |
| Hypopituitarism |
4.0% |
| Hypothalamo-pituitary Disorder |
4.0% |
| Panic Disorder |
4.0% |
| Acromegaly |
3.7% |
| Multiple Sclerosis |
3.7% |
| Gastrooesophageal Reflux Disease |
3.4% |
| Type 2 Diabetes Mellitus |
3.4% |
| Hyperprolactinaemia |
3.1% |
| Neuroleptic Malignant Syndrome |
3.1% |
| Parkinsonism |
3.1% |
| Blood Thyroid Stimulating Hormone Decreased |
2.8% |
| Iron Deficiency |
2.8% |
| Primary Hypothyroidism |
2.8% |
| Schizophrenia, Paranoid Type |
2.8% |
|
| Pituitary Tumour Benign |
15.3% |
| Ventricular Fibrillation |
11.1% |
| Vomiting |
9.7% |
| Neuroleptic Malignant Syndrome |
8.3% |
| Drug Eruption |
5.6% |
| Aplasia Pure Red Cell |
4.2% |
| Epilepsy |
4.2% |
| Hypotension |
4.2% |
| Upper Respiratory Tract Congestion |
4.2% |
| Weight Decreased |
4.2% |
| Weight Increased |
4.2% |
| Abdominal Distension |
2.8% |
| Anxiety |
2.8% |
| Blood Glucose Decreased |
2.8% |
| Breast Lump Removal |
2.8% |
| Cardiac Hypertrophy |
2.8% |
| Cerebrovascular Accident |
2.8% |
| Conjunctivitis |
2.8% |
| Depression |
2.8% |
| Dizziness |
2.8% |
|
| Interacting |
| Post-traumatic Epilepsy |
29.0% |
| Prolactinoma |
23.7% |
| Respiratory Tract Infection |
14.0% |
| Convulsion |
12.9% |
| Vulvovaginal Mycotic Infection |
10.8% |
| Hyperprolactinaemia |
3.2% |
| Vaginal Lesion |
3.2% |
| B-cell Lymphoma |
1.1% |
| Epilepsy |
1.1% |
| Parkinson's Disease |
1.1% |
|
| Galactorrhoea |
22.2% |
| Menstrual Disorder |
22.2% |
| Mucosal Dryness |
18.5% |
| Psychomotor Hyperactivity |
11.1% |
| Diplopia |
7.4% |
| Abnormal Behaviour |
3.7% |
| Drug Interaction |
3.7% |
| Malaise |
3.7% |
| Orthostatic Hypotension |
3.7% |
| Treatment Noncompliance |
3.7% |
|
